Synbal is a San Diego-based platform company founded on the CRISPR-based breakthrough genome editing technologies developed at the University of California, San Diego (UCSD). Active Genetics is a powerful new technology platform that has the potential to dramatically accelerate genetic manipulations in virtually any organism or cell. It has broad applications in a wide variety of organisms, as well as offering game-changing approaches to improve patient-specificity and efficiency/functionality of cell-therapy strategies.

DISCOVER MORE

OUR MISSION

Employ our unique, patented Active Genetics platform to selectively engineer or modify the genetics of any organism or cell to enhance human well-being.

  • At the somatic cell level this includes developing modified or engineered cells as biotherapeutics in applicable diseases including but not exclusively, cancer, autoimmune disease, tissue regeneration, neurological and metabolic diseases.

  • At the germ cell level this includes engineering or modifying animals for research and veterinary use.

DISCOVER MORE

OUR PLATFORM

Active Genetics is a Bioengineering Platform with multiple opportunities in human and veterinary health

Synbal is exploring application of its proprietary platform in the following areas

  • Somatic Cell-based modifications for drug discovery
  • Immuno-oncology
  • Regenerative medicine
  • Animal models
  • Veterinary applications

DISCOVER MORE

OUR TEAM

  • David Webb
    David Webb CEO

    Former VP of Research, Celgene

  • Clyde Shores
    Clyde Shores VP, Business Development and Operations

    Former Abbott, Amgen, Baxter

  • Dan Koeppen
    Dan Koeppen Legal Affairs

    Wilson Sonsini Goodrich Rosati

  • Tsvi Goldenberg
    Tsvi Goldenberg Chairman of the Board & Founder

    Former CEO at Itherx (Immusol)

  • Ethan Bier
    Ethan Bier Board Member & Founder

    Distinguished Professor, UC San Diego

  • Valentino Gantz
    Valentino Gantz Board Member & Founder

    Assistant Research Scientist, UC San Diego

  • Rick Morrissey
    Rick Morrissey President Biotech Development

    Former VP of Development, Celgene

  • Stephen Hedrick
    Stephen Hedrick Distinguished Professor, UC San Diego

    Co-discoverer of the T-Cell Receptor

CONTACT US

captcha txt
Not readable? Change text.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt